Clinical Trial Update: A Study to Evaluate Safety of Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety of upadacitinib in combination with topical corticosteroids for moderate to severe atopic dermatitis in adolescents and adults c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Upadacitinib (upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED